Drug
Fnp 223
Fnp 223: highest development phase Phase 2, developed by Ferrer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ferrer
Trials
| Drug | Phase | Indication |
|---|---|---|
| FNP-223 NCT06355531 | Phase 2 | Progressive Supranuclear Palsy |
Latest
No recent events.
Follow Fnp 223 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.